Abstract
Phenotypic and genotypic methods were used to characterize extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli isolated in 2007 from 11 different Canadian medical centers. Of the 209 ESBLproducing E. coli isolates tested, 148 (71%) produced CTX-M-15, 17 (8%) produced CTX-M-14, 5 (2%) produced CTX-M-3, and 1 produced CTX-M-27. Overall, 96 (46%) of the ESBL producers belonged to clonal complex ST131, with the highest prevalence in Brampton, Calgary, and Winnipeg. ST131 is an important cause of community onset urinary tract infections due to ESBL-producing E. coli across Canada. Copyright © 2010, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Peirano, G., Richardson, D., Nigrin, J., McGeer, A., Loo, V., Toye, B., … Pitout, J. D. D. (2010). High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-β-lactamase-producing Escherichia coli isolates from Canada. Antimicrobial Agents and Chemotherapy, 54(3), 1327–1330. https://doi.org/10.1128/AAC.01338-09
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.